BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Pathophysiol. Dec 22, 2025; 16(4): 110243
Published online Dec 22, 2025. doi: 10.4291/wjgp.v16.i4.110243
Table 1 Age-adjusted rates
Variables
Overall
Male
Female
Incidence [age-adjusted rate (95%CI) per 100000 people]
Sex
Male4.1 (4.0-4.1)N/AN/A
Female0.9 (0.9-1.0)N/AN/A
Race/ethnicity
NH White2.7 (2.6-2.7)4.6 (4.5-4.7)1.0 (1.0-1.0)
NH Black2.2 (2.1-2.3)3.6 (3.4-3.8)1.2 (1.4-1.4)
NH AI/AN1.9 (2.6-3.3)4.4 (3.8-5.1)1.6 (1.3-2.0)
NH Asian/PI1.5 (1.4-1.5)2.6 (2.4-2.7)0.6 (0.5-0.7)
Hispanic1.7 (1.6-1.8)3.1 (2.9-3.2)0.6 (0.5-0.7)
Staging
In situ0.0 (0.0-0.0)0.0 (0.0-0.0)0.0 (0.0-0.0)
Localized0.5 (0.5-0.5)0.9 (0.9-0.9)0.2 (0.2-0.3)
Regional0.8 (0.8-0.8)1.4 (1.4-1.4)0.4 (0.3-0.4)
Distant1.0 (1.0-1.0)1.8 (1.7-1.8)0.3 (0.3-0.4)
Mortality [age-adjusted rate (95%CI) per 100000 people]
Sex
Male3.4 (3.4-3.5)N/AN/A
Female0.7 (0.7-0.8)N/AN/A
Race/ethnicity
NH White2.1 (2.1-2.2)3.8 (3.7-3.9)0.8 (0.8-0.8)
NH Black2.0 (1.9-2.1)3.3 (3.1-3.5)1.1 (1.0-1.2)
NH AI/AN2.5 (2.2-2.8)3.8 (3.2-4.5)1.4 (1.1-1.8)
NH Asian/PI1.2 (1.1-1.2)2.1 (2.0-2.2)0.4 (0.4-0.5)
Hispanic1.4 (1.3-1.5)2.6 (2.5-2.8)0.5 (0.4-0.5)
Staging
In situ0.0 (0.0-0.0)0.0 (0.0-0.0)0.0 (0.0-0.0)
Localized0.4 (0.3-0.4)0.6 (0.6-0.7)0.2 (0.2-0.2)
Regional0.6 (0.6-0.7)1.1 (1.1-1.2)0.3 (0.2-0.3)
Distant0.9 (0.9-0.9)1.6 (1.6-1.7)0.3 (0.3-0.3)
Table 2 Annual percent change in age-adjusted incidence rates of esophageal cancer by race/ethnicity and stage at diagnosis stratified by sex

Male
P value
Female
P value
Incidence [annual % change (95%CI)]
Race/ethnicity
NH White-0.75 (-1.13 to -0.28)0.004-0.11 (-1.17 to 0.92)0.79
NH Black-3.54 (-4.74 to -2.33)< 0.001-3.40 (-5.29 to -1.41)0.003
NH AI/AN-0.62 (-2.28 to 1.40)0.56-1.88 (-3.41 to -0.077)0.039
NH Asian/PI1.67 (-2.06 to 6.52)0.31-2.67 (-6.80 to 2.17)0.27
Hispanic-0.97 (-2.71 to 1.07)0.35-0.064 (-2.27 to 2.60)0.95
Staging
In situN/AN/A
Localized-2.76 (-4.24 to -1.58)< 0.001-1.98 (-4.48 to 0.12)0.059
Regional-0.73 (-1.81 to 0.32)0.14-0.40 (-1.39 to 0.56)0.39
Distant-0.43 (-1.00 to 0.13)0.12-14.096 (-2.54 to 0.35)0.12
Mortality [annual % change (95%CI)]
Race/ethnicity
NH White1.03 (-0.22 to 2.39)0.110.65 (-0.60 to 2.01)0.32
NH Black-1.98 (-4.36 to 0.67)0.14-0.78 (-2.97 to 1.53)0.51
NH AI/AN3.09 (-0.53 to 8.28)0.091-0.091 (-4.68 to 6.73)0.83
NH Asian/PI-0.14 (-1.64 to 1.65)0.95-0.67 (-3.02 to 2.52)0.76
Hispanic0.50 (-0.63 to 1.81)0.362.24 (0.42-4.99)0.021
Staging
In situN/AN/A
Localized0.71 (-0.82 to 2.39)0.350.23 (-1.62 to 2.30)0.82
Regional0.92 (-0.39 to 2.42)0.170.86 (-0.50 to 2.36)0.22
Distant0.22 (-1.00 to 1.47)0.68-0.051 (-1.39 to 1.49)0.93
Table 3 Incidence rate ratios to associate the rate of esophageal cancer incidence with age, sex, race and stage at diagnosis
Variables
Overall [IRR (95%CI)]
P value
Males [IRR (95%CI)]
P value
Females [IRR (95%CI)]
P value
Age
< 20Reference< 0.001Reference< 0.001Reference< 0.001
20-291.13 (0.97-1.32)1.21 (0.97-1.49)1.06 (0.84-1.32)
30-391.71 (1.48-1.97)2.21 (1.82-2.68)1.21 (0.97-1.50)
40-494.98 (4.40-5.64)7.61 (6.42-9.02)2.34 (1.93-2.83)
50-5916.6 (14.8-18.6)26.2 (22.3-31.8)6.88 (5.79-8.16)
60-6928.5 (25.4-31.9)45.8 (39.0-53.8)11.1 (9.38-13.1)
70-7925.2 (22.4-28.3)37.9 (32.3-44.6)12.3 (10.4-14.5)
80 +15.4 (13.7-17.3)20.8 (17.7-24.5)9.88 (8.35-11.7)
Sex
MaleReference< 0.001N/AN/A
Female0.32 (0.31-0.33)N/AN/A
Race
NH WhiteReference< 0.001Reference< 0.001Reference< 0.001
NH Black0.12 (0.11-0.12)0.096 (0.091-0.10)0.19 (0.18-0.21)
NH American Indian/Alaskan Native0.04 (0.036-0.042)0.028 (0.026-0.031)0.077 (0.068-0.086)
NH Asian/Pacific Islander0.13 (0.13-0.14)0.12 (0.11-0.13)0.17 (0.15-0.18)
Hispanic0.15 (0.14-0.15)0.14 (0.14-0.15)0.16 (0.14-0.18)
Staging
In situReference< 0.001Reference< 0.001Reference< 0.001
Localized2.47 (2.35-2.58)3.68 (3.46-3.93)1.24 (1.15-1.34)
Regional3.81 (3.64-3.98)5.85 (5.50-6.22)1.76 (1.64-1.89)
Distant4.57 (4.37-4.78)7.43 (6.99-7.89)1.71 (1.59-1.84)
Year of diagnosis1.09 (1.08-1.09)< 0.0011.09 (1.09-1.10)< 0.0011.08 (1.08-1.08)< 0.001
Table 4 Incidence rate ratios to associate the rate of esophageal cancer mortality with age, sex, race and stage at diagnosis
Variables
Overall [IRR (95%CI)]
P value
Males [IRR (95%CI)]
P value
Females [IRR (95%CI)]
P value
Age
< 20Reference< 0.001Reference< 0.001Reference< 0.001
20-291.06 (0.90-1.24)1.09 (0.88-1.37)1.03 (0.81-1.28)
30-391.42 (1.22-1.65)1.70 (1.39-2.09)1.14 (0.92-1.41)
40-493.42 (3.01-3.89)5.17 (4.34-6.15)1.66 (1.36-2.04)
50-5911.4 (10.1-12.8)18.1 (15.4-21.4)4.64 (3.88-5.53)
60-6920.9 (18.7-23.5)33.9 (28.9-39.8)7.89 (6.66-9.35)
70-7921.1 (18.8-23.7)32.2 (27.4-37.9)9.98 (8.43-11.8)
80 +16.6 (14.9-18.9)23.3 (19.8-27.4)10.3 (8.70-12.2)
Sex
MaleReference< 0.001N/AN/A
Female0.32 (0.31-0.33)N/AN/A
Race
NH WhiteReference< 0.001Reference< 0.001Reference< 0.001
NH Black0.13 (0.12-0.14)0.11 (0.10-0.11)0.21 (0.19-0.23)
NH American Indian/Alaskan Native0.045 (0.042-0.049)0.032 (0.029-0.036)0.091 (0.081-0.10)
NH Asian/Pacific Islander0.13 (0.13-0.14)0.12 (0.12-0.13)0.17 (0.15-0.18)
Hispanic0.15 (0.15-0.16)0.15 (0.14-0.15)0.17 (0.16-0.19)
Staging
In situReference< 0.001Reference< 0.001Reference< 0.001
Localized1.60 (1.52-1.68)2.36 (2.21-2.53)0.84 (0.77-0.91)
Regional2.91 (2.78-3.05)4.53 (4.25-4.82)1.30 (1.20-1.40)
Distant4.16 (3.98-4.35)6.76 (6.37-7.19)1.56 (1.45-1.67)
Year of diagnosis1.10 (1.09-1.10)-1.10 (1.10-1.11)---